Abstracts of the NIH‐FDA Conference “Biomarkers and Surrogate Endpoints: Advancing Clinical Research and Applications” | Zendy

Donna Mildvan | Zendy; Jonathan Kagan | Zendy; Scott L. Zeger | Zendy; B. Michael Silber | Zendy; Barbara A. Cornblatt | Zendy; Kathleen R. Merikangas | Zendy; James Eberwine | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Abstracts of the NIH‐FDA Conference “Biomarkers and Surrogate Endpoints: Advancing Clinical Research and Applications”

Author(s) -

Donna Mildvan,

Jonathan Kagan,

Scott L. Zeger,

B. Michael Silber,

Barbara A. Cornblatt,

Kathleen R. Merikangas,

James Eberwine

Publication year - 1998

Publication title -

disease markers

Language(s) - English

Resource type - Journals

eISSN - 1875-8630

pISSN - 0278-0240

DOI - 10.1155/1998/698239

Subject(s) - surrogate endpoint , clinical trial , medicine , biomarker , antiretroviral therapy , clinical endpoint , natural history , psychological intervention , disease , human immunodeficiency virus (hiv) , intensive care medicine , natural history study , biomarker discovery , clinical research , oncology , immunology , bioinformatics , viral load , biology , biochemistry , psychiatry , gene , proteomics

s of the NIH-FDA Conference “Biomarkers and Surrogate Endpoints: Advancing Clinical Research and Applications” Abstracts of the NIH-FDA Conference 188s of the NIH-FDA Conference 188

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research